Establishment of high-titer HCV and SARS-CoV-2 production in a scalable packed-bed bioreactor for inactivated vaccines inducing neutralizing antibodies in animals
Research output: Contribution to conference › Poster › Communication
Original language | English |
---|---|
Publication date | 6 Jul 2022 |
Publication status | Published - 6 Jul 2022 |
Event | HCV Flavi 2022 - Ghent, Belgium Duration: 6 Jul 2022 → 9 Jul 2022 |
Conference
Conference | HCV Flavi 2022 |
---|---|
Country | Belgium |
City | Ghent |
Period | 06/07/2022 → 09/07/2022 |
ID: 311703598